Early compensatory responses against neuronal injury: A new therapeutic window of opportunity for Alzheimer's Disease?
- PMID: 30101571
- PMCID: PMC6436584
- DOI: 10.1111/cns.13050
Early compensatory responses against neuronal injury: A new therapeutic window of opportunity for Alzheimer's Disease?
Abstract
Alzheimer's disease (AD) is characterized by extensive neurodegeneration and inflammation in selective brain areas, linked to severely disabling cognitive deficits. Before full manifestation, different stages appear with progressively increased brain pathology and cognitive impairment. This significantly extends the time lag between initial molecular triggers and appearance of detectable symptoms. Notably, a number of studies in the last decade have revealed that in the early stage of mild cognitive impairment, events that appear in contrast with neuronal distress may occur. These have been reproduced in vitro and in animal models and include increase in synaptic elements, increase in synaptic and metabolic activity, enhancement of neurotrophic milieu and changes in glial cell reactivity and inflammation. They have been interpreted as compensatory responses that could either delay disease progression or, in the long run, result detrimental. For this reason, these mechanisms define a new and previously undervalued window of opportunity for intervention. Their importance resides especially in their early appearance. Directing efforts to better characterize this stage, in order to identify new pharmacological targets, is an exciting new avenue to future advances in AD research.
Keywords: beta-amyloid; cognitive impairment; compensation; glial reactivity; neurodegeneration.
© 2018 John Wiley & Sons Ltd.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures

Similar articles
-
(-)-P7C3-S243 Protects a Rat Model of Alzheimer's Disease From Neuropsychiatric Deficits and Neurodegeneration Without Altering Amyloid Deposition or Reactive Glia.Biol Psychiatry. 2018 Oct 1;84(7):488-498. doi: 10.1016/j.biopsych.2017.10.023. Epub 2017 Nov 6. Biol Psychiatry. 2018. PMID: 29246437 Free PMC article.
-
A Novel Therapeutic Approach to Treat Alzheimer's Disease by Neurotrophic Support During the Period of Synaptic Compensation.J Alzheimers Dis. 2018;62(3):1211-1218. doi: 10.3233/JAD-170839. J Alzheimers Dis. 2018. PMID: 29562539 Free PMC article. Review.
-
NMDA neurotransmission dysfunction in mild cognitive impairment and Alzheimer's disease.Curr Pharm Des. 2014;20(32):5169-79. doi: 10.2174/1381612819666140110115603. Curr Pharm Des. 2014. PMID: 24410566 Review.
-
Angelica tenuissima Nakai Ameliorates Cognitive Impairment and Promotes Neurogenesis in Mouse Model of Alzheimer's Disease.Chin J Integr Med. 2018 May;24(5):378-384. doi: 10.1007/s11655-017-2812-2. Epub 2017 Jun 3. Chin J Integr Med. 2018. PMID: 28578486
-
Cortical thickness is associated with altered autonomic function in cognitively impaired and non-impaired older adults.J Physiol. 2017 Nov 15;595(22):6969-6978. doi: 10.1113/JP274714. Epub 2017 Oct 25. J Physiol. 2017. PMID: 28952161 Free PMC article.
Cited by
-
The Neurodegenerative Elderly Syndrome (NES) hypothesis: Alzheimer and Parkinson are two faces of the same disease.IBRO Neurosci Rep. 2022 Sep 26;13:330-343. doi: 10.1016/j.ibneur.2022.09.007. eCollection 2022 Dec. IBRO Neurosci Rep. 2022. PMID: 36247524 Free PMC article. Review.
-
Upregulated ECM genes and increased synaptic activity in Parkinson's human DA neurons with PINK1/ PRKN mutations.NPJ Parkinsons Dis. 2024 May 18;10(1):103. doi: 10.1038/s41531-024-00715-0. NPJ Parkinsons Dis. 2024. PMID: 38762512 Free PMC article.
-
Effects of accelerated intermittent theta-burst stimulation combined with cognitive training on brain function in amnestic mild cognitive impairment patients.Neurol Sci. 2025 Jul 14. doi: 10.1007/s10072-025-08315-3. Online ahead of print. Neurol Sci. 2025. PMID: 40658276
-
Cellular and Molecular Events Leading to Paraquat-Induced Apoptosis: Mechanistic Insights into Parkinson's Disease Pathophysiology.Mol Neurobiol. 2022 Jun;59(6):3353-3369. doi: 10.1007/s12035-022-02799-2. Epub 2022 Mar 19. Mol Neurobiol. 2022. PMID: 35306641 Free PMC article. Review.
-
SWATH-MS analysis of cerebrospinal fluid to generate a robust battery of biomarkers for Alzheimer's disease.Sci Rep. 2020 May 4;10(1):7423. doi: 10.1038/s41598-020-64461-y. Sci Rep. 2020. PMID: 32366888 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical